Mediclin AG
Mediclin AG (MED.DE) Stock Overview
Explore Mediclin AG’s financial performance, market position, analyst ratings, and future outlook.
MED.DE Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Mediclin AG (MED.DE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $2.36.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 5.78 and a market capitalization of 143.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute, Acute, and Other Activities segments. It offers medical services in the areas of neurology, psychosomatics, orthopaedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, surgery, nursing care, and others. The company also provides services in the areas of ENT and acute outpatient services. As of December 31, 2021, it owned 34 clinics, 7 nursing care facilities, and 11 medical care centres with a total capacity of 7,831 beds and 482 nursing places in 11 German federal states. The company is headquartered in Offenburg, Germany.
Joachim Ramming
7,292
Okenstrasse 27, Offenburg
2000